Amrize Ltd $AMRZ Shares Sold by Generali Asset Management SPA SGR

Generali Asset Management SPA SGR reduced its stake in shares of Amrize Ltd (NYSE:AMRZFree Report) by 21.7% in the third quarter, Holdings Channel.com reports. The institutional investor owned 77,772 shares of the company’s stock after selling 21,581 shares during the period. Generali Asset Management SPA SGR’s holdings in Amrize were worth $3,774,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently added to or reduced their stakes in the stock. BNP Paribas Financial Markets acquired a new position in shares of Amrize during the second quarter valued at $59,000. Groupe la Francaise bought a new stake in Amrize in the 2nd quarter valued at about $60,000. Allianz SE bought a new stake in Amrize in the 2nd quarter valued at about $80,000. Osaic Holdings Inc. acquired a new position in Amrize during the 2nd quarter valued at about $90,000. Finally, Norman Fields Gottscho Capital Management LLC grew its position in Amrize by 24.8% in the 3rd quarter. Norman Fields Gottscho Capital Management LLC now owns 10,155 shares of the company’s stock worth $493,000 after purchasing an additional 2,015 shares during the last quarter.

Analyst Ratings Changes

AMRZ has been the topic of a number of recent analyst reports. Wells Fargo & Company lifted their price target on Amrize from $57.00 to $58.00 and gave the company an “overweight” rating in a report on Thursday, October 30th. Sanford C. Bernstein restated an “outperform” rating and issued a $70.00 target price on shares of Amrize in a research report on Thursday, December 18th. Vertical Research began coverage on Amrize in a research report on Tuesday, November 25th. They set a “hold” rating and a $54.00 price target for the company. Oddo Bhf started coverage on Amrize in a research note on Monday, November 3rd. They issued a “neutral” rating for the company. Finally, Kepler Capital Markets raised shares of Amrize to a “strong-buy” rating in a report on Tuesday, October 21st. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and seven have given a Hold rating to the company’s stock. According to data from MarketBeat, Amrize presently has an average rating of “Moderate Buy” and a consensus target price of $60.00.

Check Out Our Latest Report on Amrize

Insider Buying and Selling

In related news, CEO Jan Philipp Jenisch acquired 55,000 shares of the business’s stock in a transaction on Thursday, October 30th. The shares were purchased at an average price of $52.64 per share, for a total transaction of $2,895,200.00. Following the acquisition, the chief executive officer owned 1,505,000 shares in the company, valued at approximately $79,223,200. This represents a 3.79% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CTO Roald Brouwer acquired 4,000 shares of Amrize stock in a transaction on Friday, October 31st. The shares were purchased at an average cost of $51.77 per share, with a total value of $207,080.00. Following the completion of the purchase, the chief technology officer directly owned 9,000 shares of the company’s stock, valued at approximately $465,930. This represents a 80.00% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders purchased 65,000 shares of company stock valued at $3,399,720 over the last ninety days.

Amrize Stock Performance

Shares of NYSE AMRZ opened at $55.39 on Friday. Amrize Ltd has a 1 year low of $44.12 and a 1 year high of $56.76. The company has a market cap of $30.63 billion and a price-to-earnings ratio of 30.10. The firm’s fifty day moving average price is $52.20. The company has a current ratio of 1.45, a quick ratio of 0.85 and a debt-to-equity ratio of 0.38.

Amrize (NYSE:AMRZGet Free Report) last announced its quarterly earnings data on Wednesday, October 29th. The company reported $0.98 earnings per share for the quarter, missing the consensus estimate of $1.01 by ($0.03). The firm had revenue of $3.68 billion during the quarter, compared to analyst estimates of $3.49 billion. The firm’s revenue for the quarter was up 6.6% on a year-over-year basis.

Amrize Profile

(Free Report)

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

Read More

Want to see what other hedge funds are holding AMRZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amrize Ltd (NYSE:AMRZFree Report).

Institutional Ownership by Quarter for Amrize (NYSE:AMRZ)

Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.